1. Home
  2. GBIO vs MSAI Comparison

GBIO vs MSAI Comparison

Compare GBIO & MSAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • MSAI
  • Stock Information
  • Founded
  • GBIO 2016
  • MSAI 1995
  • Country
  • GBIO United States
  • MSAI United States
  • Employees
  • GBIO N/A
  • MSAI N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • MSAI
  • Sector
  • GBIO Health Care
  • MSAI
  • Exchange
  • GBIO Nasdaq
  • MSAI Nasdaq
  • Market Cap
  • GBIO 29.5M
  • MSAI 25.9M
  • IPO Year
  • GBIO 2020
  • MSAI N/A
  • Fundamental
  • Price
  • GBIO $5.99
  • MSAI $0.72
  • Analyst Decision
  • GBIO Buy
  • MSAI Strong Buy
  • Analyst Count
  • GBIO 4
  • MSAI 1
  • Target Price
  • GBIO $10.67
  • MSAI $2.50
  • AVG Volume (30 Days)
  • GBIO 70.7K
  • MSAI 107.3K
  • Earning Date
  • GBIO 11-05-2025
  • MSAI 11-11-2025
  • Dividend Yield
  • GBIO N/A
  • MSAI N/A
  • EPS Growth
  • GBIO N/A
  • MSAI N/A
  • EPS
  • GBIO N/A
  • MSAI N/A
  • Revenue
  • GBIO $21,230,000.00
  • MSAI $5,591,000.00
  • Revenue This Year
  • GBIO N/A
  • MSAI $24.16
  • Revenue Next Year
  • GBIO N/A
  • MSAI $102.22
  • P/E Ratio
  • GBIO N/A
  • MSAI N/A
  • Revenue Growth
  • GBIO 61.15
  • MSAI N/A
  • 52 Week Low
  • GBIO $3.00
  • MSAI $0.52
  • 52 Week High
  • GBIO $29.10
  • MSAI $3.33
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 54.23
  • MSAI 49.50
  • Support Level
  • GBIO $5.51
  • MSAI $0.68
  • Resistance Level
  • GBIO $6.04
  • MSAI $0.77
  • Average True Range (ATR)
  • GBIO 0.32
  • MSAI 0.06
  • MACD
  • GBIO -0.08
  • MSAI 0.00
  • Stochastic Oscillator
  • GBIO 64.86
  • MSAI 42.91

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About MSAI Infrared Cameras Holdings Inc.

MultiSensor AI Holdings Inc build and deploy intelligent multi-sensing platforms incorporating edge and cloud software solutions that leverage artificial intelligence (AI). It is a provider of sensing systems built around high-resolution thermal imagers, visible and acoustic imagers, as well as vibration and laser spectroscopy sensors, that perceive and measure heat, sound, vibration, and gas in industrial assets and the surrounding environment, helping companies gain insight to protect and manage their most important assets and infrastructure. It also offers a wide range of form factors for its sensor devices, including, among other form factors, small to large handheld designs with built-in displays and controls, and fixed-mounted single- and multi-sensor camera sensor systems.

Share on Social Networks: